Home / Stocks / AUROLAB
Back to all stocks
BSE · AUROLAB

Auro Laboratories Ltd. (AUROLAB) Share Price

Sector: Healthcare · ISIN: INE292C01011

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,690
of 5,047 stocks
▲ 61W▲ 191M
Peak #2,604 · 02 Oct 2026

Operating in Healthcare, Auro Laboratories Ltd. is growing revenue rapidly, commands a premium earnings multiple, and posts a modest return on equity. Ownership as of Jun 2026.

Market Cap
146.53 Cr
P/E Ratio
41.46
P/B Ratio
3.16
ROE
7.62%
ROCE
9.95%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
Revenue13.94 Cr8.77 Cr9.83 Cr9.39 Cr
Net Profit1.17 Cr1.05 Cr97.06 L1.95 Cr
EPS1.881.681.563.13
Operating Profit3.26 Cr2.50 Cr3.09 Cr3.26 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
52.40%
Public
47.60%

PUBLIC BREAKDOWN

DII
0.01%
MF (within DII)
0.01%
Individuals
42.73%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs